(A, B) Expression dynamics of Tnf (A) and Hgf (B) in uninjured and regenerating muscle tissue determined by qPCR. (C) Expression dynamics of Hgf in quiescent and activated muscle stem cells and in …
Quantification of Tnf, Hgf and Met expression represented in the diagrams shown in A-D.
The microarray data sets were obtained from the GEO Database under the accession numbers GSE103684 and GSE47177. Symbols represent the mean of three independent biological replicates, error bars …
(A–D) Immunohistological analysis of regenerating (7 days post injury [dpi] and 20 dpi) muscle of control and coMet mutants using antibodies against laminin (red) and sarcomeric myosin (green). DAPI …
Quantification of fiber diameters represented in the diagrams shown in E, J and O.
(A–D) Immunohistological analysis of uninjured and regenerating (7 days post injury [dpi]) muscle of control and coMet mice using antibodies against laminin (red) and PAX7 (green). DAPI was used as …
Quantification of PAX7+ cells represented in the diagrams shown in E, F, K, L, Q and R (Figure 3).
Quantification of recombination efficiency of the Metflox allele represented in the diagrams shown in B, C and D (Figure 3—figure supplement 1).
(A) Cartoon showing the unspliced transcripts from the Metflox allele before and after Cre-dependent excision of exon 17. Arrows mark position of qPCR primers used to determine the recombination …
(A) Expression dynamics of Cxcl12 in uninjured and regenerating muscle tissue determined by qPCR. (B) Expression levels of Cxcl12 in quiescent and activated muscle stem cells and in muscle tissue …
Quantification of Cxcl12 and Cxcr4 expression represented in the diagrams shown in A-C.
The microarray data sets were obtained from the GEO Database under the accession numbers GSE103684 and GSE47177. Symbols represent the mean of three independent biological replicates, error bars …
(A–D) Immunohistological analysis of regenerating (7 days post injury [dpi]) muscle of control, TxGakaCxcr4, TxGakaMet, and TxGakaCxcr4;Met mice using antibodies against laminin (red) and sarcomeric …
Quantification of fiber diameters, PAX7+ cells and fibrotic area represented in the diagrams shown in E, J (Figure 5), E (Figure 5—figure supplement 1) and E, F (Figure 5—figure supplement 2).
(A–D) Immunohistological analysis of uninjured muscle of control, TxGakaCxcr4, TxGakaMet, andTxGakaCxcr4;Met mice using antibodies against laminin (red) and PAX7 (green). DAPI was used as a …
(A–D, A′–D′) Immunohistological analysis of regenerating muscle at 7 days post injury (dpi) of control, TxGakaCxcr4, TxGakaMet, and TxGakaCxcr4;Met mutants using antibodies against F4/80 (red in A–D,…
(A–D, A′–D′) Immunohistological analysis of apoptotic cells. PAX7 antibody staining (red) was combined with TUNEL assay (green) to identify apoptotic muscle stem cells in injured muscle of control, …
Quantification of PAX7+TUNEL+ and PAX7+ cells represented in the diagrams shown in E and F (Figure 6).
Quantification of EdU+PAX7+ cells represented in the diagram shown in E (Figure 6—figure supplement 1). Quantification of MYOG+ and PAX7+ cells represented in the diagrams shown in E and F (Figure 6—figure supplement 2).
(A–D) Identification of proliferating muscle stem cells by EdU incorporation in regenerating muscle of (A) control, (B) TxGakaCxcr4, (C) TxGakaMet, and (D) TxGakaCxcr4;Met mice at 4 days post injury …
(A–D) Identification of differentiating myogenic cells in regenerating muscle of (A) control, (B) TxGakaCxcr4, (C) TxGakaMet, and (D) TxGakaCxcr4;Met mice at 4 days post injury (dpi) using …
(A–C) Primary muscle stem cells were isolated and cultured for 3 hr in the presence of TNFα plus/minus HGF and Cxcl12. Apoptotic cells were identified by TUNEL staining. (D) Quantification of TUNEL+ …
Quantification of TUNEL+, PAX7+ and PAX7+TUNEL+ cells represented in the diagrams shown in D, G, H, K, L, O and P (Figure 7).
Quantification of TUNEL+ cells represented in the diagram shown in Figure 7—figure supplement 1.
C2C12 cells were cultured for 24 hr in the presence of TNFα plus/minus different concentration of neutralizing TNFα antibody. Apoptotic cells were identified by TUNEL staining and quantified.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Antibody | Guinea pig polyclonal anti-PAX7 | Our lab | PMID:22940113 | 1:2500 |
Antibody | Rabbit polyclonal anti-Laminin | Sigma-Aldrich | L9393RRID:AB_477163 | 1:500 |
Antibody | Goat polyclonalanti-CollagenIV | Millipore | AB769RRID:AB_92262 | 1:500 |
Antibody | Mouse monoclonalanti-sarcomeric myosin | DSHB | MF20RRID:AB_2147781 | 1:10 |
Antibody | Rabbit polyclonalanti-Myogenin | Abcam | ab124800RRID:AB_10971849 | 1:1000 |
Antibody | Mouse monoclonal anti-F4/80 | Abcam | ab6640RRID:AB_1140040 | 1:100 |
Antibody | Rabbit polyclonal anti-fibronectin | Sigma-Aldrich | F7387RRID:AB_476988 | 1:500 |
Antibody | Cy2, Cy3, Cy5 conjugated antibodies | Dianova | 1:500 | |
Commercial assay or kit | In Situ Cell Death Detection Kit | Roche | 12156792910 | |
Commercial assay or kit | EdU | baseclick GmbH | BCK-EdU647 | |
Commercial Assay or kit | qPCR SYBR Green Mix | ThermoFisher | AB1158B | |
Sequence-based reagent | ATCCACGATGTTCATGAGAG | Eurofins | N/A | qPCR HGF (forward primer) |
Sequence-based reagent | GCTGACTGCATTTCTCATTC | Eurofins | N/A | qPCR HGF (reverse primer) |
Sequence-based reagent | CACAGAAAGCATGATCCGCGACGT | Eurofins | N/A | qPCR TNF (forward primer) |
Sequence-based reagent | CGGCAGAGAGGAGGTTGACTTTCT | Eurofins | N/A | qPCR TNF (reverse primer) |
Sequence-based reagent | CAGAGCCAACGTCAAGCA | Eurofins | N/A | qPCR Cxcl12 (forward primer) |
Sequence-based reagent | AGGTACTCTTGGATCCAC | Eurofins | N/A | qPCR Cxcl12 (reverse primer) |
Sequence-based reagent | CATTTTGGCTGTGTCTATCATG | Eurofins | N/A | qPCR Met (forward primer) |
Sequence-based reagent | ACTCCTCAGGCAGATTCCC | Eurofins | N/A | qPCR Met (reverse primer) |
Sequence-based reagent | TCAGTGGCTGACCTCCTCTT | Eurofins | N/A | qPCR CXCR4 (forward primer) |
Sequence-based reagent | CTTGGCCTTTGACTGTTGGT | Eurofins | N/A | qPCR CXCR4 (reverse primer) |
Sequence-based reagent | CATTTTGGCTGTGTCTATCATG | Eurofins | N/A | qPCR Met Exon 17 (forward primer) |
Sequence-based reagent | ACTCCTCAGGCAGATTCCC | Eurofins | N/A | qPCR Met Exon 18 (reverse primer) |
Sequence-based reagent | CTTGCCAGAGACATGTACGAT | Eurofins | N/A | qPCR Met Exon 20 (forward primer) |
Sequence-based reagent | AGGAGCACACCAAAGGACCA | Eurofins | N/A | qPCR Met Exon 21 (reverse primer) |
Sequence-based reagent | CCAGTTGGTAACAATGCCATGT | Eurofins | N/A | qPCR β-actin (forward primer) |
Sequence-based reagent | GGCTGTATTCCCCTCCATCG | Eurofins | N/A | qPCR β-actin (reverse primer) |
Sequence-based reagent | ACTAGGCTCCACTCTGTCCTTC | Eurofins | PMID:19554048 | Genotyping PCR-Primer 1 Pax7CreERT2Fan |
Sequence-based reagent | GCAGATGTAGGGACATTCCAGTG | Eurofins | PMID:19554048 | Genotyping PCR-Primer 2 Pax7CreERT2Fan |
Sequence-based reagent | GCTGCTGTTGATTACCTGGC | Eurofins | PMID:21828091 | Genotyping PCR-Primer 1 Pax7CreERT2GaKa |
Sequence-based reagent | CTGCACTGAGACAGGACCG | Eurofins | PMID:21828091 | Genotyping PCR-Primer 2 Pax7CreERT2GaKa |
Sequence-based reagent | GCTGCTGTTGATTACCTGGC | Eurofins | PMID:21828091 | Genotyping PCR-Primer 1 Pax7CreERT2GaKa |
Sequence-based reagent | GCTCTGGATACACCTGAGTCT | Eurofins | PMID:15520281 | Genotyping PCR-Primer 1 Pax7-IRESCre |
Sequence-based reagent | GGATAGTGAAACAGGGGCAA | Eurofins | PMID:15520281 | Genotyping PCR-Primer 2 Pax7-IRESCre |
Sequence-based reagent | TCGGCCTTCTTCTAGGTTCTGCTC | Eurofins | PMID:15520281 | Genotyping PCR-Primer 3 Pax7-IRESCre |
Sequence-based reagent | CCACCCAGGACAGTGTGACTCTAA | Eurofins | PMID:15520246 | Genotyping PCR-Primer 1 Cxcr4 flox |
Sequence-based reagent | GATGGGATTCTGTATGAGGATTAGC | Eurofins | PMID:15520246 | Genotyping PCR-Primer 2 Cxcr4 flox |
Sequence-based reagent | CCAAGTGTCTGACGGCTGTG | Eurofins | N/A | Genotyping PCR-Primer 1 Met flox |
Sequence-based reagent | AGCCTAGTGGAATTCTCTGTAAG | Eurofins | N/A | Genotyping PCR-Primer 2 Met flox |
Tnf, Hgf, and Cxcl12 expression levels during muscle regeneration.
Expression levels of Tnf, Hgf, and Cxcl12 mRNA after acute injury were determined in the entire muscle by qPCR. Uninjured and 1–7 days post injury (dpi) were assessed, and expression was normalized to the expression in the uninjured muscle. The values are displayed as means ± SEM. p-Values are shown in brackets. β-Actin was used for normalization.